CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, Kun-Chieh Chen, Chia-Hung Hsu, Kang-Yi Su, Jeremy J. W. Chen, Huei-Wen Chen, Sung-Liang Yu, Tsung-Ying Yang, Gee-Chen Chang
Cancer Research and Treatment. 2018;50(4):1294-1303.   Published online 2018 January 4    DOI: https://doi.org/10.4143/crt.2017.512

Excel Download

The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Cancer Research and Treatment. 2018;50(4):1294-1303   Crossref logo
Link1 Link2 Link3

Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor
Respirology Case Reports. 2016;5(1):e00206   Crossref logo
Link1 Link2

FEASIBILITY AND CLINICAL IMPACT OF RE-BIOPSY IN ADVANCED LUNG ADENOCARCINOMA AFTER PROGRESSES DURING FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS
Respirology. 2018;23:9-9   Crossref logo
Link1 Link2

Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

OncoTargets and Therapy. 2019;Volume 12:9495-9504   Crossref logo
Link1 Link2

Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival
Lung Cancer. 2018;121:12-17   Crossref logo
Link1 Link2

Does the Addition of Vascular Endothelial Growth Factor Inhibitors to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Overcome T790M Acquired Resistance?
Journal of Thoracic Oncology. 2011;6(2):404   Crossref logo
Link1 Link2

Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
Clinical Lung Cancer. 2009;10(4):281-289   Crossref logo
Link1 Link2

Maintenance Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor after First-Line Chemotherapy in Mutation-Positive Non–Small-Cell Lung Cancer
Journal of Thoracic Oncology. 2015;10(8):e81-e82   Crossref logo
Link1 Link2

Transformation of advanced lung adenocarcinoma to acquired T790M resistance mutation adenosquamous carcinoma following tyrosine kinase inhibitor: a case report
Tumori Journal. 2020;030089162097326   Crossref logo
Link1 Link2 Link3

Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First-line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Therapy Failure
Journal of Thoracic Oncology. 2017;12(10):e171-e173   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.